Skip to content
DraconiticResearch
Search Sources API
197,768 studies31 sourcesUpdated 13 min ago
Peer-reviewedCC BY 4.0Anesthesiology

Management of Chronic Antihypertensive Medications in the Perioperative Period

Abstract

guided by patient comorbidities, surgical context, and medication-specific risks, is important to minimize hemodynamic instability and optimize surgical outcomes.

Related

  1. Best Evidence Summary of Non-Pharmacological Pain Assessment and Management in Elderly Patients During the Perioperative Period
    Lingxia Guo, Huaping Chen, Ruihua Zhang +6
    Journal of Pain ResearchPeer-reviewedCC BY-NC 4.0Full textSurgery & anaesthesiaPMC
  2. Lung ultrasound-guided protocolized fluid management versus conventional central venous pressure-based management in monitoring extravascular lung water during the perioperative period of percutaneous nephrolithotomy: a randomized controlled trial.
    Xuan Yu, Zhiwei Wang, Xinpeng Xu +4
    Annals of medicinePeer-reviewedCC BYFull textSurgery & anaesthesiaEurope PMC
  3. The association of risk factors, circulatory biomarkers and antihypertensive medications with preeclampsia: a Mendelian randomisation analysis
    Sze Sen Wang, Devendra Meena, Jingxian Huang +3
    BMC MedicinePeer-reviewedCC BY 4.0General medicineCrossref
  4. Renoprotective vs. Antihypertensive Dosing of Renin–Angiotensin System Inhibitors in Chronic Kidney Disease: Analysis of Summary of Product Characteristics of Medicinal Products Authorized in Poland
    Marta Maciejczyk, Anna Maria Dworakowska, Magdalena Bujalska-Zadrożny
    Journal of Clinical MedicinePeer-reviewedCC BY 4.0Full textGeneral medicineCrossrefEurope PMC
  5. Risk of nephrolithiasis with finerenone versus other chronic kidney disease medications: a comparative real-world evidence study
    Yi-Hong Chen, Tung-Liang Hwang, Ze-Hong Lu +1
    Scientific ReportsPeer-reviewedCC BYFull textGeneral medicineDOAJ
BibTeX
@article{tang2026management,
  title = {{Management of Chronic Antihypertensive Medications in the Perioperative Period}},
  author = {Justine Tang and Duminda N Wijeysundera and Patrick Rossignol and Matthieu Legrand},
  journal = {Anesthesiology},
  year = {2026},
  month = sep,
  doi = {10.1097/aln.0000000000005884},
  url = {https://hal.univ-lorraine.fr/hal-05760920v1},
  note = {CC BY 4.0},
}
RIS
TY  - JOUR
TI  - Management of Chronic Antihypertensive Medications in the Perioperative Period
AU  - Justine Tang
AU  - Duminda N Wijeysundera
AU  - Patrick Rossignol
AU  - Matthieu Legrand
PY  - 2026
DA  - 2026/09/23
JO  - Anesthesiology
DO  - 10.1097/aln.0000000000005884
UR  - https://hal.univ-lorraine.fr/hal-05760920v1
AB  - guided by patient comorbidities, surgical context, and medication-specific risks, is important to minimize hemodynamic instability and optimize surgical outcomes.
SN  - 0003-3022
SN  - 1528-1175
ER  -